ConductScience.org, home

Trial · NCT01522651

Results by group35

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Atrial Fibrillation Burden (AFB) at BaselinePlacebo12.7Standard Error 2.21Percentage of total recording time
Atrial Fibrillation Burden (AFB) at BaselineRanolazine 750 mg10.8Standard Error 2.70Percentage of total recording time
Atrial Fibrillation Burden (AFB) at BaselineDronedarone 225 mg11.6Standard Error 2.47Percentage of total recording time
Atrial Fibrillation Burden (AFB) at BaselineRanolazine 750 mg + Dronedarone 225 mg11.7Standard Error 2.40Percentage of total recording time
Atrial Fibrillation Burden (AFB) at BaselineRanolazine 750 mg + Dronedarone 150 mg11.7Standard Error 2.04Percentage of total recording time
Percent Change From Baseline in Atrial Fibrillation Burden (AFB) by Week 12Placebo-5.9Standard Error 18.00percent change
Percent Change From Baseline in Atrial Fibrillation Burden (AFB) by Week 12Ranolazine 750 mg-23.0Standard Error 21.17percent change
Percent Change From Baseline in Atrial Fibrillation Burden (AFB) by Week 12Dronedarone 225 mg3.5Standard Error 15.68percent change
Percent Change From Baseline in Atrial Fibrillation Burden (AFB) by Week 12Ranolazine 750 mg + Dronedarone 225 mg-59.1Standard Error 10.47percent change
Percent Change From Baseline in Atrial Fibrillation Burden (AFB) by Week 12Ranolazine 750 mg + Dronedarone 150 mg-45.5Standard Error 10.73percent change
Absolute Change From Baseline in AFB by Week 12PlaceboBaseline16.8Standard Error 3.66percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mgBaseline17.3Standard Error 3.74percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Dronedarone 225 mgBaseline19.1Standard Error 4.14percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mg + Dronedarone 225 mgBaseline16.8Standard Error 3.11percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mg + Dronedarone 150 mgBaseline16.7Standard Error 3.52percentage of total recording time
Absolute Change From Baseline in AFB by Week 12PlaceboAbsolute Change From Baseline in AFB by Week 124.6Standard Error 3.19percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mgAbsolute Change From Baseline in AFB by Week 12-3.1Standard Error 2.17percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Dronedarone 225 mgAbsolute Change From Baseline in AFB by Week 125.6Standard Error 2.65percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mg + Dronedarone 225 mgAbsolute Change From Baseline in AFB by Week 12-4.7Standard Error 3.24percentage of total recording time
Absolute Change From Baseline in AFB by Week 12Ranolazine 750 mg + Dronedarone 150 mgAbsolute Change From Baseline in AFB by Week 12-3.9Standard Error 3.11percentage of total recording time

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01522651/results